| Identification |
| Name: | trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone |
| Synonyms: | 6-[4-[1-(trans-4-Benzyloxycyclohexyl)-1H-5-tetrazolyl]butoxy]-2-oxo-1,2,3,4-tetrahydroquinoline;trans-3,4-Dihydro-6-[4-[1-[4-(phenylmethoxy)cyclohexyl]-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinone |
| CAS: | 87152-97-4 |
| Molecular Formula: | C27H33N5O3 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C27H33N5O3/c33-27-16-9-21-18-24(14-15-25(21)28-27)34-17-5-4-8-26-29-30-31-32(26)22-10-12-23(13-11-22)35-19-20-6-2-1-3-7-20/h1-3,6-7,14-15,18,22-23H,4-5,8-13,16-17,19H2,(H,28,33)/t22?,23- |
| Molecular Structure: |
![(C27H33N5O3) 6-[4-[1-(trans-4-Benzyloxycyclohexyl)-1H-5-tetrazolyl]butoxy]-2-oxo-1,2,3,4-tetrahydroquinoline;tran...](https://img.guidechem.com/structure/87152-97-4.gif) |
| Properties |
| Flash Point: | 401.798°C |
| Boiling Point: | 740.76°C at 760 mmHg |
| Density: | 1.306g/cm3 |
| Refractive index: | 1.658 |
| Flash Point: | 401.798°C |
| Usage: | 2-Oxoquinoline derivative as blood platelet aggregation inhibitors. Intermediate of OPC-13013, a metabolite of Cilostazol |
| Safety Data |
| |
 |
